Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday - Acutus Medical (OTC:AFIB) - Benzinga

Omeros Corporation (NASDAQ:OMER) jumped 68.7% to close at $4.64.
Clovis Oncology, Inc. (NASDAQ:CLVS) gained 58.3% to settle at $2.85 on Friday.
Fast Radius, Inc. (NASDAQ:FSRD) jumped 41.2% to close at $0.8887 after jumping over 37% on Thursday. Fast Radius recently appointed Pat McCusker as President, Interim CFO and John Nanry as COO.
Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) jumped 36.5% to close at $3.55.
Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) shares jumped 36.2% to close at $0.6131 on Friday after dropping 10% on Thursday.
Inter & Co, Inc. (NASDAQ:INTR) jumped 31.9% to close at $2.77. Goldman Sachs recently initiated coverage on the stock with a Sell rating.
Shift Technologies, Inc. (NASDAQ:SFT) jumped 28.9% to close at $0.8676 after declining around 7% on Thursday.
Accolade, Inc. (NASDAQ:ACCD) climbed 28.8% to close at $9.53 after the company reported better-than-expected Q1 results.
Mega Matrix Corp. (NASDAQ:MTMT) gained 25.7% to close at $1.71.
Aspira Women's Health Inc. (NASDAQ:AWH) climbed 24.7% to close at $0.7324.
Mereo BioPharma Group plc (NASDAQ:MREO) rose 24.1% to settle at $1.39.
Tuniu Corporation (NASDAQ:TOUR) gained 23.8% to close at $1.30.
Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) shares gained 23.1% to close at $5.12. Lytus recently announced the closing of initial public offering.
Endo International plc (NASDAQ:ENDP) jumped 22.4% to close at $0.5701 after a federal jury in Chicago returned a verdict in favor of the Company in the Opana ER antitrust trial.
Belite Bio, Inc (NASDAQ:BLTE) gained 21% to close at $37.69 after Benchmark initiated coverage on the stock with a Buy rating and $57 price target.
Zhong Yang Financial Group Limited (NASDAQ:TOP) gained 20.7% to settle at $29.80.
Indaptus Therapeutics, Inc. (NASDAQ:INDP) rose 19.9% to close at $3.13.
Betterware de México, S.A.P.I. de C.V. (NASDAQ:BWMX) jumped 19.3% to close at $10.31.
INVO Bioscience, Inc. (NASDAQ:INVO) gained 19% to close at $0.7840.
Yatsen Holding Limited (NYSE:YSG) jumped 18.1% to close at $1.83.
Coupang, Inc. (NYSE:CPNG) jumped 18% to close at $15.04 after Credit Suisse upgraded the stock from Neutral to Outperform.
VerifyMe, Inc. (NASDAQ:VRME) shares rose 17.4% to close at $2.30 after the company announced liquidation of the G3 VRM Acquisition SPAC and initiated a new share repurchase program.
Tyra Biosciences, Inc. (NASDAQ:TYRA) jumped 17.2% to settle at $8.38.
2U, Inc. (NASDAQ:TWOU) gained 17% to close at $12.25. Byju's recently reportedly made an offer to acquire the company for $15 per share.
Gravitas Education Holdings, Inc. (NYSE:GEHI) gained 16.8% to close at $0.69.
Alvotech (NASDAQ:ALVO) gained 16.3% to close at $9.55. Deutsche Bank initiated coverage on Alvotech with a Hold rating and announced a price target of $10.
FedNat Holding Company (NASDAQ:FNHC) surged 16.1% to settle at $0.36.
Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) gained 16.1% to close at $1.37.
Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) jumped 16% to close at $2.47.
BioRestorative Therapies, Inc. (NASDAQ:BRTX) surged 14.8% to close at $3.4195. BioRestorative Therapies recently enrolled first patient in the phase 2 clinical study of its lead drug BRTX-100 in chronic lumbar disc disease (cLDD).
Mobiquity Technologies, Inc. (NASDAQ:MOBQ) gained 14.3% to close at $1.60.
Engine Gaming and Media, Inc. (NASDAQ:GAME) gained 12.1% to close at $0.9078.
Panbela Therapeutics, Inc. (NASDAQ:PBLA) jumped 12.1% to close at $0.74.
Sonder Holdings Inc. (NASDAQ:SOND) shares surged 11.5% to close at $1.16.
Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) gained 11% to close at $0.2120. Allena Pharmaceuticals recently announced it has terminated its previously announced at-the-market offering.
LightInTheBox Holding Co., Ltd. (NYSE:LITB) rose 10.4% to close at $1.06. LightInTheBox recently posted Q1 sales of $93.77 million.
Akebia Therapeutics, Inc. (NASDAQ:AKBA) rose 10.2% to close at $2.77 after the company executed an agreement to terminate its vadadustat Collaboration and License Agreements with Otsuka Pharmaceutical. The company will receive a $55 million settlement fee.
Larimar Therapeutics, Inc. (NASDAQ:LRMR) gained 9.7% to close at $2.15.
Etsy, Inc. (NASDAQ:ETSY) surged 9% to close at $79.81. Evercore ISI Group maintained Etsy with an Outperform and lowered the price target from $130 to $95.
ECMOHO Limited (NASDAQ:MOHO) gained 8.8% to close at $0.1787 after dropping over 4% on Thursday.
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) gained 8.6% to close at $1.89.
Cosmos Holdings Inc. (NASDAQ:COSM) rose 8.6% to settle at $0.4060. Cosmos Holdings reported a strategic R&D partnership with Cloudpharm P.C. to study the human gastrointestinal microbiome and launch related products targeting on obesity and other gut-related disorders.
Missfresh Limited (NASDAQ:MF) shares gained 8.4% to close at $0.2764 after declining around 10% on Thursday.
Tenax Therapeutics, Inc. (NASDAQ:TENX) gained 6.1% to close at $0.3182.
Synchronoss Technologies, Inc. (NASDAQ:SNCR) surged 6.1% to close at $1.22.

Talaris Therapeutics, Inc. (NASDAQ:TALS) shares dipped 49% to close at $2.30 on Friday. SVB Leerink downgraded Talaris Therapeutics from Outperform to Market Perform and lowered the price target from $21 to $7.
Agile Therapeutics, Inc. (NASDAQ:AGRX) dropped 45% to close at $0.6404 after the company priced a 26,666,666 share common stock offering at $0.90 per share.
Kalera Public Limited Company (NASDAQ:KAL) fell 38.8% to close at $3.61.
Ensysce Biosciences, Inc. (NASDAQ:ENSC) fell 34.5% to close at $0.5690 after jumping around 73% on Thursday.
Akouos, Inc. (NASDAQ:AKUS) dropped 33.7% to close at $3.11.
Cryptyde, Inc. (NASDAQ:TYDE) fell 31.5% to close at $1.39.
MMTec, Inc. (NASDAQ:MTC) fell 29.7% to close at $0.2072.
ioneer Ltd (NASDAQ:IONR) fell 28.6% to close at $12.58.
Acutus Medical, Inc. (NASDAQ:AFIB) declined 27.3% to close at $0.8143. Acutus Medical recently announced the commercial launch of its left-heart access products.
Brickell Biotech, Inc. (NASDAQ:BBI) fell 22.2% to close at $0.0980. Brickell Biotech announced a 1-for-45 reverse stock split.
Enjoy Technology, Inc. (NASDAQ:ENJY) dropped 21.3% to close at $0.1708.
Dermata Therapeutics, Inc. (NASDAQ:DRMA) shares declined 21.1% to close at $0.5130 after jumping around 20% on Thursday.
Benitec Biopharma Inc. (NASDAQ:BNTC) fell 20.3% to close at $0.9250.
Kohl's Corporation (NYSE:KSS) shares declined 19.6% to close at $28.68 after the company called off discussions to sell its business to Franchise Group Inc.
Evofem Biosciences, Inc. (NASDAQ:EVFM) dropped 19.5% to close at $0.91.
Miromatrix Medical Inc. (NASDAQ:MIRO) fell 18.1% to close at $3.27.
Yoshitsu Co., Ltd (NASDAQ:TKLF) dropped 17.8% to close at $1.39.
Redbox Entertainment Inc. (NASDAQ:RDBX) fell 17.4% to close at $6.11.
Energy Vault Holdings, Inc. (NYSE:NRGV) dropped 17.3% to close at $8.29.
Alpha Tau Medical Ltd. (NASDAQ:DRTS) fell 16% to settle at $7.57.
Celldex Therapeutics, Inc. (NASDAQ:CLDX) fell 15.8% to close at $22.70 after the company presented interim data from its Barzolvolimab Phase 1b study at EAACI 2022.
RiceBran Technologies (NASDAQ:RIBT) fell 15.4% to settle at $0.5667.
Doma Holdings Inc. (NYSE:DOMA) dropped 15.4% to close at $0.8714.
Full House Resorts, Inc. (NASDAQ:FLL) fell 14.6% to settle at $5.19.
NuCana plc (NASDAQ:NCNA) declined 14.4% to close at $0.6205.
Provention Bio, Inc. (NASDAQ:PRVB) dropped 14.3% to close at $3.43. The U.S. Food and Drug Administration (FDA) has extended its review period by three months for Provention Bio’s Biologics License Application (BLA) for teplizumab in patients with type 1 diabetes.
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) fell 13.1% to close at $0.2399.
Jiuzi Holdings, Inc. (NASDAQ:JZXN) fell 10.2% to close at $0.7880.
Revelation Biosciences, Inc. (NASDAQ:REVB) fell 6.3% to close at $1.04 after jumping 77% on Thursday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for treatment of allergic rhinitis.
Micron Technology, Inc. (NASDAQ:MU) fell 3% to close at $53.65. Micron reported upbeat financial results for its third quarter, but issued weak guidance for its fourth quarter.